Similar Search Results

Authorized generic drugs, price competition, and consumers' welfare

Berndt, Ernst R.; Mortimer, Richard; Bhattacharjya, Ashoke - In: Health affairs : at the intersection of health, health … 26 (2007) 3, pp. 790-799

Persistent link: https://www.econbiz.de/10003493146

The United States' experience with direct-to-consumer advertising of prescription drugs : what have we learned?

Berndt, Ernst R. - In: Pharmaceutical innovation : incentives, competition, …, (pp. 174-195). 2007

Persistent link: https://www.econbiz.de/10003498981

The impact of antihypertensive drugs on the number and risk of death, stroke and myocardial infarction in the United States

Long, Genia; Cutler, David M.; Berndt, Ernst R.; Royer, … - 2006

Persistent link: https://www.econbiz.de/10003302409

Can a disease-based price index improve the estimation of the Medical Consumer Price Index?

Song, Xue; Marder, William D.; Houchens, Robert L.; … - In: Price index concepts and measurement : [revised …, (pp. 329-368). 2009

Persistent link: https://www.econbiz.de/10003943338

Pricing and reimbursement in US pharmaceutical markets

Berndt, Ernst R.; Newhouse, Joseph P. - 2010

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. In this survey chapter on pricing and reimbursement in U.S. pharmaceutical markets, we first provide background information on important...

Persistent link: https://www.econbiz.de/10008656716

The effect of FDA advisories on branded pharmaceutical firms' valuations and promotion efforts

Conti, Rena M.; Huskamp, Haiden A.; Berndt, Ernst R. - 2011

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of...

Persistent link: https://www.econbiz.de/10009374023